中国新药与临床杂志2024,Vol.43Issue(9) :641-646.DOI:10.14109/j.cnki.xyylc.2024.09.01

新型抗菌药物依拉环素的研究进展

Research progress of a new antibacterial drug eravacycline

冯洁 谢俊艳 时友忠 安洪亮
中国新药与临床杂志2024,Vol.43Issue(9) :641-646.DOI:10.14109/j.cnki.xyylc.2024.09.01

新型抗菌药物依拉环素的研究进展

Research progress of a new antibacterial drug eravacycline

冯洁 1谢俊艳 1时友忠 1安洪亮1
扫码查看

作者信息

  • 1. 南京梅山医院药剂科,江苏南京 210039
  • 折叠

摘要

依拉环素是一种新型全合成的含氟四环素类抗生素,具有广谱的抗菌活性.现有的临床试验表明,依拉环素在治疗各类复杂性感染中具有很好的有效性和安全性,尤其在针对多药耐药菌方面应用前景良好.本文从该药的化学结构、作用机制、抗菌谱、药动学/药效学、临床应用、耐药性等方面进行综述,为临床用药提供依据和参考.

Abstract

Eravacycline is a new class of fully synthetic fluortetracycline antibiotics with broad-spectrum antibacterial activity.The existing clinical trials have shown that eravacycline has good efficacy and safety in the treatment of various complex infections,especially in the application of multi-drug resistant bacteria.In this paper,the chemical structure,mechanism of action,antibacterial spectrum,pharmacokinetics/pharmacodynamics,clinical application,and drug resistance of eravacycline were reviewed in order to provide basis and reference for clinical drug use.

关键词

依拉环素/药理作用机制/临床研究/抗药性,细菌

Key words

eravacycline/pharmacological mechanism of action/clinical study/drug resistance,bacterial

引用本文复制引用

出版年

2024
中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
段落导航相关论文